Non-traditional risk factors of progression of chronic kidney disease in adult population: a scoping review

Chronic kidney disease (CKD) has become a public health concern over the last several years. Nowadays developed countries spend around 3% of their annual health-care budget on patients with CKD. According to the scientific community the most remarkable risk factors for CKD are diabetes and hypertension. Unknown CKD etiology has been reported as a global phenomenon including uncommon risk factors such as: dehydration, leptospirosis, heat stress, water quality, and others. This study aims to report non-traditional risk factors for ESRD based on a scoping review methodology. The scoping review methodology described by Arksey and O’Malley was used by performing an extensive review of the information. A total of 46 manuscripts were reviewed. The non-traditional ESRD risk factors are depicted based on six categories. Gender and ethnicity have been considered as risk factors for ESRD. Erythematous systemic lupus (ESL) is reported as an important risk factor for ESRD. Pesticide use has been an significant risk factor due to its effects on human and environmental health. Some compounds commonly used in homes against insects and plants are related to ESRD. Congenital and hereditary diseases in the urinary tract have been studied as a cause of ESRD in children and young adults. End-stage renal disease is a major concern for public health on a global level. As it can be seen, non-traditional risk factors are several and have different etiologies. It is necessary to put the issue on the table and add it to the public agenda in order to find multidisciplinary solutions.

[1]  Erick Sierra-Díaz,et al.  Incidencia de fiebre y hemorragia post nefrolitotomía percutánea: un estudio de cohorte prospectivo , 2022, Cirugía y Cirujanos.

[2]  M. Bots,et al.  End-stage kidney disease in patients with clinically manifest vascular disease; incidence and risk factors: results from the UCC-SMART cohort study , 2021, Journal of Nephrology.

[3]  R. Reyes-Acevedo,et al.  High prevalence of end-stage renal disease of unknown origin in Aguascalientes Mexico: role of the registry of chronic kidney disease and renal biopsy in its approach and future directions , 2021, Clinical kidney journal.

[4]  Jenny I. Shen,et al.  The Case for Early Identification and Intervention of Chronic Kidney Disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. , 2020, Kidney international.

[5]  L. Gesualdo,et al.  Recurrent Glomerulonephritis after Renal Transplantation: The Clinical Problem , 2020, International journal of molecular sciences.

[6]  D. Henriksen,et al.  Second-generation antipsychotics and the risk of chronic kidney disease: a population-based case-control study , 2020, BMJ Open.

[7]  A. Garg,et al.  Association of Early Postdonation Renal Function With Subsequent Risk of End-Stage Renal Disease in Living Kidney Donors. , 2020, JAMA surgery.

[8]  D. Şelimen,et al.  Investigation of the Causes and Risk Factors of Previous End-Stage Renal Disease in Kidney Transplant Recipients. , 2019, Transplantation proceedings.

[9]  Nasser A. Polanco-Flores Chronic renal disease in Mexico: A preventive uncontrolled epidemic , 2019, Revista M�dica del Hospital General de M�xico.

[10]  Y. Khader,et al.  Risk Factors for End-Stage Renal Failure Among Patients on Hemodialysis in Aljomhory Hospital, Sa’adah Governorate, Yemen: Hospital-Based Case-Control Study , 2019, JMIR public health and surveillance.

[11]  O. Adejumo,et al.  Burden, psychological well-being and quality of life of caregivers of end stage renal disease patients , 2019, Ghana medical journal.

[12]  H. Choi,et al.  The risk of end-stage renal disease in systemic lupus erythematosus , 2019, Medicine.

[13]  Raj Munshi,et al.  Benefits and risks of protocol biopsies in pediatric renal transplantation , 2019, Pediatric Nephrology.

[14]  P. Stenvinkel,et al.  Chronic inflammation in end-stage renal disease and dialysis , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  V. Tesar,et al.  Mutational screening of inverted formin 2 in adult-onset focal segmental glomerulosclerosis or minimal change patients from the Czech Republic , 2018, BMC Medical Genetics.

[16]  Rajeev Sharma,et al.  Utility of Serial Protocol Biopsies Performed After 1 Year in Predicting Long-Term Kidney Allograft Function According to Histologic Phenotype. , 2018, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.

[17]  G. García-García,et al.  The Tragedy of Having ESRD in Mexico , 2018, Kidney international reports.

[18]  L. Dello Strologo,et al.  Protocol biopsies in pediatric renal transplantation: a precious tool for clinical management , 2018, Pediatric Nephrology.

[19]  E. Sierra-Diaz,et al.  Exposure to Radioactive Emanations of Medical Personnel in Percutaneous Nephrolithotomy , 2018, Dose-response : a publication of International Hormesis Society.

[20]  M. Pontes,et al.  Prevalence of clinically validated primary causes of end-stage renal disease (ESRD) in a State Capital in Northeastern Brazil , 2018, Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia.

[21]  Marcello Tonelli,et al.  The global burden of kidney disease and the sustainable development goals , 2018, Bulletin of the World Health Organization.

[22]  E. Sierra-Diaz,et al.  Prevalence of Albuminuria in Children Living in a Rural Agricultural and Fishing Subsistence Community in Lake Chapala, Mexico , 2017, International journal of environmental research and public health.

[23]  F. Kronenberg,et al.  Associations between genetic risk variants for kidney diseases and kidney disease etiology , 2017, Scientific Reports.

[24]  F. Kronenberg,et al.  Associations between genetic risk variants for kidney diseases and kidney disease etiology , 2017, Scientific Reports.

[25]  C. Lewis,et al.  Obesity increases the risk of end-stage renal disease among living kidney donors. , 2017, Kidney international.

[26]  Ashutosh Kumar Singh,et al.  Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, The Lancet.

[27]  Ashutosh Kumar Singh,et al.  Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, Lancet.

[28]  M. Pavkovic,et al.  Environmental exposure to arsenic and chromium in children is associated with kidney injury molecule-1. , 2016, Environmental research.

[29]  T. Hussain,et al.  Risk Factors of End Stage Renal Disease in Peshawar, Pakistan: Odds Ratio Analysis , 2016, Open access Macedonian journal of medical sciences.

[30]  L. Plantinga,et al.  Association of age with health-related quality of life in a cohort of patients with systemic lupus erythematosus: the Georgians Organized Against Lupus study , 2016, Lupus Science & Medicine.

[31]  D. Richardson,et al.  Pesticide exposure and end-stage renal disease risk among wives of pesticide applicators in the Agricultural Health Study. , 2015, Environmental research.

[32]  K. Elmusharaf,et al.  Causes of end stage renal failure among haemodialysis patients in Khartoum State/Sudan , 2015, BMC Research Notes.

[33]  G. Nagel,et al.  Sex- and Time-Dependent Patterns in Risk Factors of End-Stage Renal Disease: A Large Austrian Cohort with up to 20 Years of Follow-Up , 2015, PloS one.

[34]  S. Navaneethan,et al.  Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease , 2015, American Journal of Nephrology.

[35]  G. Trifirò,et al.  Association of Individual Non-Steroidal Anti-Inflammatory Drugs and Chronic Kidney Disease: A Population-Based Case Control Study , 2015, PloS one.

[36]  Luxia Zhang,et al.  Status of non‐steroidal anti‐inflammatory drugs use and its association with chronic kidney disease: A cross‐sectional survey in China , 2014, Nephrology.

[37]  Paul Komenda,et al.  Cost-effectiveness of primary screening for CKD: a systematic review. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[38]  L. Boulware,et al.  Disparities in the burden, outcomes, and care of chronic kidney disease , 2014, Current opinion in nephrology and hypertension.

[39]  J. Sommar,et al.  End-stage renal disease and low level exposure to lead, cadmium and mercury; a population-based, prospective nested case-referent study in Sweden , 2013, Environmental Health.

[40]  A. Matas,et al.  Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody‐Mediated Rejection and Nonadherence , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[41]  N. Breslow,et al.  Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor. , 2011, The Journal of urology.

[42]  J. Boavida,et al.  Prevalence of Chronic Kidney Disease and Associated Risk Factors, and Risk of End-Stage Renal Disease: Data from the PREVADIAB Study , 2011, Nephron Clinical Practice.

[43]  Mohamed Elsharif,et al.  Causes of end-stage renal disease in Sudan: a single-center experience. , 2011, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[44]  Chun-Yuh Yang,et al.  Analgesic use and the risk for progression of chronic kidney disease , 2010, Pharmacoepidemiology and drug safety.

[45]  A K Mathur,et al.  Geographic Variation in End‐Stage Renal Disease Incidence and Access to Deceased Donor Kidney Transplantation , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[46]  V. Salomaa,et al.  Risk factors for end‐stage renal disease in a community‐based population: 26‐year follow‐up of 25 821 men and women in eastern Finland , 2009, Journal of internal medicine.

[47]  S. Haghpanah,et al.  Causes of chronic renal failure among Iranian hemodialysis patients. , 2009, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[48]  C. McCulloch,et al.  Risk factors for end-stage renal disease: 25-year follow-up. , 2009, Archives of internal medicine.

[49]  J. Góngora-Ortega,et al.  Prevalencia de enfermedad renal crónica en niños de Aguascalientes, México , 2008 .

[50]  A. Bello,et al.  Socioeconomic status and chronic kidney disease at presentation to a renal service in the United Kingdom. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[51]  S. Sindel,et al.  Quality of life in hemodialysis, peritoneal dialysis, and transplantation patients. , 2007, Transplantation proceedings.

[52]  F. Galli Protein damage and inflammation in uraemia and dialysis patients. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[53]  M. Tonelli,et al.  NSAID use and progression of chronic kidney disease. , 2007, The American journal of medicine.

[54]  S. Lipsitz,et al.  Geographical patterns of end-stage renal disease incidence and risk factors in rural and urban areas of South Carolina. , 2007, Health & place.

[55]  Carlos Iribarren,et al.  Body Mass Index and Risk for End-Stage Renal Disease , 2006, Annals of Internal Medicine.

[56]  X. Vidal,et al.  Case-control study of regular analgesic and nonsteroidal anti-inflammatory use and end-stage renal disease. , 2005, Kidney international.

[57]  W. Hörl,et al.  Protocol biopsies after kidney transplantation , 2005, Transplant international : official journal of the European Society for Organ Transplantation.

[58]  H. Arksey,et al.  Scoping studies: towards a methodological framework , 2005 .

[59]  T. Harrer,et al.  Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus , 2002, Annals of the rheumatic diseases.

[60]  P. Whelton,et al.  Recreational drug use: a neglected risk factor for end-stage renal disease. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[61]  J. Lv,et al.  Prevalence and Disease Burden of Chronic Kidney Disease. , 2019, Advances in experimental medicine and biology.

[62]  A. Ruiz-Martinez,et al.  Renal Doppler ultrasound resistive index vs. renal scintigraphy with 99mTc-DTPA as diagnostic test for ureteropelvic junction obstruction in children. , 2019, Actas urologicas espanolas.

[63]  A. Matamala,et al.  MYH9 Associated nephropathy. , 2018, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[64]  M. Jankowska,et al.  Inflammation and Protein-Energy Wasting in the Uremic Milieu. , 2017, Contributions to nephrology.

[65]  G. García-García,et al.  Burden of end-stage renal disease (ESRD) in Latin America. , 2016, Clinical nephrology.

[66]  Brenda R. Hemmelgarn,et al.  Notice , 2012, Kidney International Supplements.

[67]  P. Kimmel,et al.  Quality of life in patients with chronic kidney disease: focus on end-stage renal disease treated with hemodialysis. , 2006, Seminars in nephrology.

[68]  A. Collins,et al.  Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors. , 2004, Advances in renal replacement therapy.